Search Results – Inserm Transfert

Our Technology Offers

Welcome to our Technology Offers website

You want access to an innovative offer which is based on the excellence of Inserm, the leading academic research and clinical institute dedicated to human health in Europe? Find out our technologies offers of patents and research tools: here is a sample of our patents.

BIO22037-R1

Device Field of development:

Respiratory Disease Therapy Area:

Target Type of patent:

Cd38 as a biomarker and biotarget in cell-lymphomas

Lorem ipsum […]

BIO19413-D1

Biomarker Field of development:

Respiratory Disease Therapy Area:

Method Type of patent:

Methods and compositions for treating cell senescence accumulation

The inventors have surprisingly demonstrated that GD3 positive senescent cells inhibit NK cell in vitro and in vivo while GD3 negative senescent cells […]

BIO16260-T1

Drug Field of development:

Respiratory Disease Therapy Area:

Use of antagonists of th17 cytokines for the treatment of bronchial

Bronchial remodelling is a prominent feature of severe asthma and a potential therapeutic target. Some data indicate that Th17 cytokines in particular […]

BIO15170-T1

Drug Field of development:

Respiratory Disease Therapy Area:

Product Type of patent:

New antisense oligonucleotide targeting all cystic fibrosis patients

The present invention relates to methods and pharmaceutical compositions for the treatment of cystic fibrosis (CF). In particular, the present […]

BIO18140-T1

Drug Field of development:

Respiratory Disease Therapy Area:

Method for treating t- helper type 2 mediated disease

The present invention relates to the treatment of T- helper type 2 (Th2)-mediated disease. Here, the inventors set out to investigate at the genome […]

BIO17336-T1

Drug Field of development:

Respiratory Disease Therapy Area:

Product Type of patent:

Methods and composition for the treatment of allergic asthma

The present invention relates to a method of treating allergic asthma in a subject in need thereof comprising a step of administering to said subject […]

BIO18240-T1

Drug Field of development:

Respiratory Disease Therapy Area:

Product Type of patent:

Antibodies specific for il20-rb and uses thereof for the treatment of

Chronic obstructive pulmonary disease (COPD) remains a major cause of morbidity and mortality worldwide. Acute exacerbation of COPD (AE-COPD) in […]

BIO17093-D1

Biomarker Field of development:

Respiratory Disease Therapy Area:

Method Type of patent:

Methods for predincting the risk of developing pulmonary

The present invention relates to methods for predicting the risk of developing pulmonary colonization/infection by P. aeruginosa. The inventors […]

BIO19413-T1

Drug Field of development:

Respiratory Disease Therapy Area:

Target Type of patent:

Methods and compositions for treating cell senescence accumulation

The inventors have surprisingly demonstrated that GD3 positive senescent cells inhibit NK cell in vitro and in vivo while GD3 negative senescent cells […]

CHIM19384-T1

Drug Field of development:

Respiratory Disease Therapy Area:

Method Type of patent:

Selective pharmacological inhibition of epac1 for the treatment of

The present invention relates to the treatment of idiopathic pulmonary fibrosis. Today, there is no cure for IPF. The inventors showed that EPAC1 […]

147

56

310

46

Our Technology Offers

Cd38 as a biomarker and biotarget in cell-lymphomas

Methods and compositions for treating cell senescence accumulation

Use of antagonists of th17 cytokines for the treatment of bronchial

New antisense oligonucleotide targeting all cystic fibrosis patients

Method for treating t- helper type 2 mediated disease

Methods and composition for the treatment of allergic asthma

Antibodies specific for il20-rb and uses thereof for the treatment of

Methods for predincting the risk of developing pulmonary

Methods and compositions for treating cell senescence accumulation

Selective pharmacological inhibition of epac1 for the treatment of

You might also be interested in

Mkpatentcrmfinalmarket

Testsynchrotheracrm1904

Cd38 as a biomarker and biotarget in

Methods of enhancing the potency of incretin-based

Apelin analogs for the treatment of heart failure

Monoacylglycerol lipase as target for the

Treatment of bone mineral density related diseases

Methods and compositions for treating skin

Use of coumarin derivatives for the preparation of

Ctip fusion to cas9 enhances transgene integration

Methods and compositions for treating cell

In vitro tests allowing to identify the potential